亚辉龙跨界布局脑机接口 上交所火速问询合作可行性、合理性

Core Viewpoint - Aihui Long (688575.SH) announced a strategic cooperation with Shenzhen Brain Machine Starlink Technology Co., Ltd. to explore brain-computer interface technology, which has raised regulatory concerns due to the sudden nature of the announcement and the company's recent poor performance in its core business [2][3][5]. Group 1: Company Announcement and Market Reaction - Aihui Long signed a strategic cooperation framework agreement with Brain Machine Starlink on January 6, focusing on brain-computer interface technology development and commercialization [2]. - Following the announcement, Aihui Long's stock price surged from 14.64 CNY to 15.80 CNY, marking a 6.52% increase with a trading volume up by 299% compared to the previous day [2]. - The Shanghai Stock Exchange issued an inquiry to Aihui Long regarding the feasibility of the cooperation, including questions about the partnership's rationale and potential insider trading [2][5]. Group 2: Financial Performance and Concerns - Aihui Long's financial performance has been declining, with a 7.69% drop in revenue and a 72.36% decrease in net profit for the first three quarters of 2025 [3][6]. - The company is attempting to pivot into the growing brain-computer interface market amid stagnation in its core business of in vitro diagnostic instruments [3]. - The inquiry from the exchange also focused on the reasons behind the significant decline in Aihui Long's financials and the potential impact of the new cooperation on its existing business [6]. Group 3: Details on the Cooperation Partner - Brain Machine Starlink was established only four months prior to the announcement, with a registered capital of 5 million CNY and a focus on comprehensive diagnosis, treatment, and rehabilitation of brain diseases [3][4]. - Both companies share the same registered address in Shenzhen, raising questions about the legitimacy and depth of the partnership [4]. - The products under development by Brain Machine Starlink, including non-invasive brain-computer interface devices, are still in early stages and have not yet entered the registration phase [4].